General Information
Drug ID
DR01246
Drug Name
Succinate
Drug Type
Small molecular drug
Indication Dietary supplements [ICD11: 5B7Z] Investigative
Formula
C4H4O4-2
Canonical SMILES
C(CC(=O)[O-])C(=O)[O-]
InChI
InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2
InChIKey
KDYFGRWQOYBRFD-UHFFFAOYSA-L
CAS Number
CAS 56-14-4
Pharmaceutical Properties Molecular Weight 116.07 Topological Polar Surface Area 80.3
Heavy Atom Count 8 Rotatable Bond Count 1
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4
XLogP
0.7
PubChem CID
160419
ChEBI ID
CHEBI:30031
DT(s) Transporting This Drug NaCT Transporter Info Sodium-coupled citrate transporter Substrate [1]
NADC3 Transporter Info Sodium/dicarboxylate cotransporter 3 Substrate [2]
Drug-Transporter Activity Data
Drug-Transporter Activity Data NADC3 Transporter Info Km = 112 microM HEK293T cells-NADC3 [2]
References
1 SLC13 family of Na+ coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):299-312.
2 SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.